-transparent.png){kind=logo}
Debrisoquine hydroxylation polymorphism was studied in 155 Finns and 70 Lapps. The frequency of the poor metabolizer phenotype was 3.2% among Finns (95% confidence interval 0.4-6.0%) and 8.6% among Lapps (95% confidence interval 2.0-15.1%).
Related Publications
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
February 1993,
Pharmacology & toxicology,
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
March 1989,
Lancet (London, England),
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
January 1970,
Human heredity,
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
February 1999,
Acta psychiatrica Scandinavica,
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
November 1990,
Diabetes research (Edinburgh, Scotland),
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
January 1978,
Hereditas,
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
June 1994,
Pharmacogenetics,
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
September 1984,
Lancet (London, England),
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
December 1984,
Lancet (London, England),
P Arvela, and
M Kirjarinta, and
M Kirjarinta, and
N Kärki, and
O Pelkonen
January 1988,
Human heredity,
